These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12789606)

  • 21. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatments for methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Corey GR
    Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
    Socha AM; LaPlante KL; Rowley DC
    Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of staphylococcal resistance.
    Shorr AF
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S171-6. PubMed ID: 17712743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
    Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
    Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Matsuhisa E; Takata H; Takata T; Atsumi K; Iwamatsu K; Shitara E
    Bioorg Med Chem; 2007 Oct; 15(19):6379-87. PubMed ID: 17681767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of antibiotics on methicillin-resistant Staphylococcus aureus.
    Dancer SJ
    J Antimicrob Chemother; 2008 Feb; 61(2):246-53. PubMed ID: 18057071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-MRSA agents: under investigation, in the exploratory phase and clinically available.
    Bryskier A
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):505-53. PubMed ID: 16107196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
    Chambers HF; Hegde SS
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):333-5. PubMed ID: 17547497
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bacterial envelope as a target for novel anti-MRSA antibiotics.
    Van Bambeke F; Mingeot-Leclercq MP; Struelens MJ; Tulkens PM
    Trends Pharmacol Sci; 2008 Mar; 29(3):124-34. PubMed ID: 18262289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting.
    Draghi DC; Sheehan DF; Hogan P; Sahm DF
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):129-33. PubMed ID: 16542812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.